| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |